GlassScriptPhysician profile
Simon N Powell
NPI 1487670782
$19,571.92
in general payments reported to CMS, 2019-2025
4 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $3,000 · 2022: $5,123 · 2023: $1,224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $593 · Food and Beverage: $365 · Consulting Fee: $266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $593.28 |
| Food and Beverage | $364.58 |
| Consulting Fee | $265.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Uk Limited | $9,675.94 | 2019 | |
| F. Hoffmann-La Roche Ag | $5,122.60 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $4,223.72 | 2020-2023 | |
| Varian Medical Systems, INC. | $549.66 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Powell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.